SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-17-044160
Filing Date
2017-07-10
Accepted
2017-07-10 06:04:00
Documents
2
Group Members
ABG II-SO LTDABG INNOVATION-SO LTDABG MANAGEMENT LTD.ABG SRNE LTDALLY BRIDGE GROUP INNOVATION CAPITAL PARTNERS III, L.P.ALLY BRIDGE LB HEALTHCARE MASTER FUND LTDALLY BRIDGE LB MANAGEMENT LTDLI BINYU FAN

Document Format Files

Seq Description Document Type Size
1 SC 13D a17-17070_1sc13d.htm SC 13D 328488
2 EX-99.1 a17-17070_1ex99d1.htm EX-99.1 42209
  Complete submission text file 0001104659-17-044160.txt   372740
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Subject) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-82540 | Film No.: 17956272
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address ABG MGMT LTD., UNIT 3002-3004, 30 FL GLOUCESTER TWR LANDMK 15 QUEENS RD CTRL HONG KONG F4 00000
Business Address ABG MGMT LTD., UNIT 3002-3004, 30 FL GLOUCESTER TWR LANDMK 15 QUEENS RD CTRL HONG KONG F4 00000 (852) 3121-9699
Ally Bridge Group Capital Partners II, L.P. (Filed by) CIK: 0001609313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: SC 13D